Precision Optics Inc Quick Ratio (POCI) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Precision Optics Corporation Inc   (NASDAQ: POCI)

Precision Optics Inc 's Quick Ratio

POCI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Precision Optics Inc 's Cash & cash equivalent grew by 1111.6 % in the Q3 2026 sequentially, faster than Current Liabilities, this led to improvement in Precision Optics Inc 's Quick Ratio to 1.05, above Precision Optics Corporation Inc average Quick Ratio.

Within Medical Equipment & Supplies industry 101 other companies have achieved higher Quick Ratio than Precision Optics Inc in third quarter 2026. While Quick Ratio total ranking has improved so far during the Q3 2026 to 1659, from total ranking in the second quarter 2025 at 2395.

Explain Quick Ratio?
How much Cash & cash equivalents POCI´s has?
What are POCI´s Current Liabilities?




POCI Quick Ratio (Mar 31 2026)
Q3
(Dec 31 2025)
Q2
(Sep 30 2025)
Q1
(Jun 30 2025)
Q4
(Mar 31 2025)
Q3
Y / Y Current Liabilities Change 103.48 % 55.16 % 42.75 % 25.36 % -2.29 %
Y / Y Cash & cash equivalent Change 319.17 % 314.93 % 119.03 % 337.66 % 175.43 %
Quick Ratio MRQ 1.05 0.09 0.18 0.29 0.51
POCI's Total Ranking # 1659 # 2395 # 2316 # 2439 # 1738
Seq. Current Liabilities Change 2.43 % 30.63 % 23.83 % 22.8 % -21.89 %
Seq. Cash & cash equivalent Change 1111.6 % -36.68 % -21.52 % -30.38 % 1099.33 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 102
Healthcare Sector # 602
Overall Market # 1659


Quick Ratio Statistics
High Average Low
3.73 0.55 0.01
(Dec 31 2012)   (Jun 30 2011)




Financial Statements
Precision Optics Inc 's Current Liabilities $ 10 Millions Visit POCI's Balance sheet
Precision Optics Inc 's Cash & cash equivalent $ 11 Millions Visit POCI's Balance sheet
Source of POCI's Sales Visit POCI's Sales by Geography


Cumulative Precision Optics Inc 's Quick Ratio

POCI's Quick Ratio for the trailling 12 Months

POCI Quick Ratio

(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
(Mar 31 2025)
12 Months
Y / Y Current Liabilities TTM Growth 56.53 % 31.89 % 27.99 % 17.65 % 9.28 %
Y / Y Cash & cash equivalent TTM Growth 287.44 % 202.76 % 100.69 % 40.18 % -38.77 %
Quick Ratio TTM 0.43 0.23 0.24 0.23 0.18
Total Ranking TTM # 2986 # 2111 # 3069 # 3184 # 2615
Seq. Current Liabilities TTM Growth 18.04 % 14.04 % 9.96 % 5.74 % -0.54 %
Seq. Cash & cash equivalent TTM Growth 123.3 % 11.29 % 14.63 % 36 % 74.5 %


On the trailing twelve months basis POCI Cash & cash equivalent more than doubled by 319.17 % in Q3 2026 year on year, faster than Current Liabilities, this led to increase in in Precision Optics Inc 's Quick Ratio to 0.43, above POCI average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 177 other companies have achieved higher Quick Ratio than Precision Optics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2025 from 2111 to 2986.

Explain Quick Ratio?
How much Cash & cash equivalents POCI´s has?
What are POCI´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 178
Healthcare Sector # 817
Within the Market # 2986


trailing twelve months Quick Ratio Statistics
High Average Low
0.76 0.28 0.1
(Sep 30 2019)   (Dec 31 2024)




Companies with similar Quick Ratio in the quarter ending Mar 31 2026, within Medical Equipment & Supplies Industry Quick RatioMar 31 2026 MRQ Cash & cash equivalentMar 31 2026 MRQ Current Liabilities
Tandem Diabetes Care Inc   2.86 $ 570.256  Millions$ 199.075  Millions
Valion Bio Inc   2.76 $ 7.215  Millions$ 2.615  Millions
Longduoduo Co Ltd  2.74 $ 0.667  Millions$ 0.244  Millions
Staar Surgical Co  2.69 $ 163.889  Millions$ 60.994  Millions
Neuraxis Inc   2.62 $ 7.079  Millions$ 2.697  Millions
Bluejay Diagnostics Inc  2.61 $ 3.684  Millions$ 1.414  Millions
Edwards Lifesciences Corporation  2.61 $ 3,671.500  Millions$ 1,409.000  Millions
Medinotec Inc   2.54 $ 2.757  Millions$ 1.086  Millions
Modular Medical Inc  2.39 $ 6.942  Millions$ 2.905  Millions
Merit Medical Systems Inc  2.37 $ 488.080  Millions$ 205.646  Millions
Seastar Medical Holding Corp  2.37 $ 9.348  Millions$ 3.948  Millions
Intuitive Surgical Inc   2.36 $ 4,517.300  Millions$ 1,911.000  Millions
Tela Bio Inc   2.22 $ 39.541  Millions$ 17.833  Millions
Plus Therapeutics Inc   2.21 $ 15.114  Millions$ 6.824  Millions
Solana Company  2.19 $ 4.395  Millions$ 2.003  Millions
Dariohealth Corp   2.17 $ 20.264  Millions$ 9.357  Millions
Pavmed Inc   2.10 $ 6.460  Millions$ 3.076  Millions
Inogen Inc   2.08 $ 110.171  Millions$ 52.865  Millions
Genedx Holdings Corp   2.07 $ 170.685  Millions$ 82.510  Millions
Atricure Inc   2.00 $ 146.165  Millions$ 73.191  Millions
Co diagnostics Inc   1.92 $ 8.231  Millions$ 4.285  Millions
Warby Parker Inc   1.88 $ 288.246  Millions$ 153.282  Millions
Femasys Inc   1.71 $ 5.386  Millions$ 3.155  Millions
Myomo Inc   1.67 $ 15.696  Millions$ 9.385  Millions
Electromed Inc   1.66 $ 16.985  Millions$ 10.226  Millions
Neuroone Medical Technologies Corp  1.66 $ 2.804  Millions$ 1.690  Millions
Axe Compute Inc  1.64 $ 6.925  Millions$ 4.227  Millions
Si bone inc   1.61 $ 33.535  Millions$ 20.829  Millions
Nephros Inc   1.59 $ 4.018  Millions$ 2.527  Millions
Logicmark Inc  1.55 $ 2.110  Millions$ 1.361  Millions

Date modified: 2026-09-08T15:11:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.